Discover Background Data and Resources:

• Get introduced to NETEC through the interactive timeline of special pathogens below.* This timeline describes some significant special pathogen events in recent history.

• Find out more about the 2014 Ebola outbreak and the development of the ASPR/CDC-supported network of healthcare facilities preparing for the next outbreak through the Ebola timeline.

• This NETEC Repository helps to provide training and educational resources to prepare for future special pathogen events.

• Explore the files BELOW THE TIMELINE to discover and learn more about Ebola and other Special Pathogens, an overview of special pathogens, clinically managing patients affected, and readying healthcare teams and systems to keep everyone safe.

Timeline of Special Pathogens:

*Click for a screen reader accessible table of this timeline.

Collection Resources

• 

  Public Engagement Project on Medical Service Prioritization During an Influenza Pandemic

  Mots-clés Ethics, Flu, Influenza, Pandemic, R-T&C, Treatment and Care
  Créateur: Public Health - Seattle & King County
  Sujet: Treatment & Care
  Type d'élément: Guide
  Date de la dernière mise à jour: 2009-09-29
  Description: A severe influenza pandemic will have profound impact on the health care delivery system. Shortages of life-sustaining medical resources, including hospital beds, trained health care providers, intensive care unit resources, medical supplies,…

• Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

  Mots-clés Ebola, Pediatrics, R-Res&Pub, R-SP, Therapeutics, Vaccine Study, Viral Hemorrhagic Fever
  Créateur: Tapia, Milagritos D., Samba O. Sow, Khardiata D. Mbaye, Aliou Thiongane, Birahim P. Ndiaye, Cheikh T. Ndour, Souleymane Mboup, Babajide Keshinro, Thompson N. Kinge, Guy Vernet, Jean Joel Bigna, Stephen Oguche, Kwadwo A. Koram, Kwaku P. Asante,…
  Sujet: Research
  Type d'élément: Publication
  Date de la dernière mise à jour: 2020-03-19
  Description: During the large 2013–16 Ebola virus outbreak caused by the Zaire Ebola virus, about 20% of cases were reported in children. This study is the first, to our knowledge, to evaluate an Ebola vaccine in children younger than 6 years.

• Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

  Mots-clés Ebola, R-Res&Pub, Therapeutics, Vaccine Study, Viral Hemorrhagic Fever
  Créateur: Tapia, Milagritos D., Samba O. Sow, Birahim P. Ndiaye, Khardiata D. Mbaye, Aliou Thiongane, Cheikh T. Ndour, Souleymane Mboup, Julie A. Ake, Babajide Keshinro, Gideon A. Akintunde, Thompson N. Kinge, Guy Vernet, Jean Joel Bigna, Stephen Oguche,…
  Sujet: Research
  Type d'élément: Publication
  Date de la dernière mise à jour: 2020-03-19
  Description: The 2014 Zaire Ebola virus disease epidemic accelerated vaccine development for the virus.

• Chimpanzee adenovirus type 3 vectored Ebola vaccine: expanding the field

  Mots-clés Ebola, R-Res&Pub, Therapeutics, Vaccine Study, Viral Hemorrhagic Fever
  Créateur: Bavari, Sina, and Patrick L. Iversen.
  Sujet: Research
  Type d'élément: Publication
  Date de la dernière mise à jour: 2020-03-19
  Description: Two phase 2 randomised clinical trials evaluating ChAd3-EBO-Z administered to healthy adults in Cameroon, Mali, Nigeria, and Senegal and healthy children in Mali and Senegal are reported by Milagritos Tapia and colleagues in The Lancet Infectious…

• Getting to zero in the DR Congo Ebola outbreak

  Mots-clés Ebola, Infection Prevention and Control, R-Res&Pub, R-T&C
  Créateur: Dhillon, Ranu S., Devabhaktuni Srikrishna, and Gerardo Chowell.
  Sujet: Infection Control
  Type d'élément: Publication
  Date de la dernière mise à jour: 2020-03-09
  Description: Any plan to stop the ongoing Ebola outbreak in eastern DR Congo must be based on a quantitative understanding of the proportion of the at-risk population that needs to be protected by effective control measures for transmission to decline…

• Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States

  Mots-clés Ebola, Epidemiology, R-Res&Pub, Viral Hemorrhagic Fever
  Créateur: Dean, Christina L., Jay W. Hooper, John M. Dye, Samantha E. Zak, Scott A. Koepsell, Laurence Corash, Richard J. Benjamin, Steve Kwilas, Shannon Bonds, Anne M. Winkler, and Colleen S. Kraft.
  Sujet: Research
  Type d'élément: Publication
  Date de la dernière mise à jour: 2020-03-04
  Description: In 2014, passive immunization by transfusion of Ebola convalescent plasma (ECP) was considered for treating patients with acute Ebola virus disease (EVD).

• Ebola virus disease

  Mots-clés Ebola, R-Gen, R-Res&Pub, Special Pathogens, Viral Hemorrhagic Fever
  Créateur: Jacob, Shevin T., Ian Crozier, William A. Fischer, Angela Hewlett, Colleen S. Kraft, Marc-Antoine de La Vega, Moses J. Soka, Victoria Wahl, Anthony Griffiths, Laura Bollinger, and Jens H. Kuhn.
  Sujet: General
  Type d'élément: Publication
  Date de la dernière mise à jour: 2020-02-20
  Description: Ebola virus disease (EVD) is a severe and frequently lethal disease caused by Ebola virus (EBOV).

• Update on Ebola Treatment Center Costs and Sustainability, United States, 2019

  Mots-clés Ebola, Example, Isolate, Isolation/Biocontainment, Physical Infrastructure, R-Lead, R-PhIn, R-Res&Pub, Special Pathogens, Treatment Facility, Zoonotic
  Créateur: Herstein, Jocelyn J., Aurora B. Le, Lily A. McNulty, Sean A. Buehler, Paul D. Biddinger, Angela L. Hewlett, John J. Lowe, and Shawn G. Gibbs.
  Sujet: Physical Infrastructure
  Type d'élément: Publication
  Date de la dernière mise à jour: 2020-05-17
  Description: We surveyed 56 Ebola treatment centers (ETCs) in the United States and identified costs incurred since 2014 ($1.76 million/ETC) and sustainability strategies.

  Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.

• 

  The Respiratory Protection Effectiveness Clinical Trial (ResPECT): a cluster-randomized comparison of respirator and medical mask effectiveness against respiratory infections in healthcare personnel

  Mots-clés Airborne Transmission, Mask, Masks, N95, Occupational Exposure, R-PPE, R-Res&Pub, Respiratory Pathogen
  Créateur: Radonovich, Lewis J., Mary T. Bessesen, Derek A. Cummings, Aaron Eagan, Charlotte Gaydos, Cynthia Gibert, Geoffrey J. Gorse, Ann-Christine Nyquist, Nicholas G. Reich, Maria Rodrigues-Barradas, Connie Savor-Price, Ronald E. Shaffer, Michael S.…
  Sujet: Infection Control
  Type d'élément: Publication
  Date de la dernière mise à jour: 2016-06-02
  Description: Although N95 filtering facepiece respirators and medical masks are commonly used for protection against respiratory infections in healthcare settings, more clinical evidence is needed to understand the optimal settings and exposure circumstances for…
• 

  Effectiveness of cough etiquette maneuvers in disrupting the chain of transmission of infectious respiratory diseases.

  Mots-clés Airborne Transmission, Infection Prevention and Control, R-PPE, R-Res&Pub, Respiratory Pathogen
  Créateur: Zayas, Gustavo, Ming C. Chiang, Eric Wong, Fred MacDonald, Carlos F. Lange, Ambikaipakan Senthilselvan, and Malcolm King.
  Sujet: Research
  Type d'élément: Publication
  Date de la dernière mise à jour: 2013-09-08
  Description: The effectiveness of recommended measures, such as "cover your mouth when coughing", in disrupting the chain of transmission of infectious respiratory diseases (IRD) has been questioned.